Advanced Biomedical Research
Toxic epidermal necrolysis in hemodialysis patient
Authors
- Uday Venkat Mateti 1
- Shankar Prasad Nagaraju 2
- Manohar Bairy 2
- Ravindra Prabhu Attur 2
- Anantha Naik Nagappa 1
- Anuradha Calicut Kini Rao 3
1 Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India
2 Department of Nephrology, Kasturba Medical College, Kasturba Hospital, Manipal University, Manipal, Karnataka, India
3 Department of Pathology, Kasturba Medical College, Kasturba Hospital, Manipal University, Manipal, Karnataka, India
Abstract
Toxic epidermal necrolysis (TEN) is a rare and life-threatening allergic drug reaction. We report a 26-year-old young female with end-stage renal disease on maintenance hemodialysis developing TEN while on filgrastim and phenytoin. It was successfully treated with intravenous immunoglobulins and steroids.
Keywords
| 1. |
Endorf FW, Cancio LC, Gibran NS. Toxic epidermal necrolysis clinical guidelines. J Burn Care Res 2008;29:706-12.  |
| 2. |
Fernández FA, Pintor E, Quesada R, Garcés FJ. Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy. Actas Dermosifiliogr 2007;98:483-5. |
| 3. |
Radhakrishnan K, Nayak SD, Kumar SP, Sarma PS. Profile of antiepileptic pharmacotherapy in a tertiary referral center in South India: A pharmacoepidemiologic and pharmacoeconomic study. Epilepsia 1999;40:179-85. |
| 4. |
Mathur S, Sen S, Ramesh L, M-Kumar S. Utilization pattern of antiepileptic drugs and their adverse effects, in a teaching hospital. Asian J Pharm Clin Res 2010;3:55-9. |
| 5. |
Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008;128:35-44.
|
)